Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-25

Clinical Trial Update: Lidocaine Infusion for Chronic Pain in Opioid Dependent Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating lidocaine infusion for chronic pain in opioid-dependent patients; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Chronic Pain | Phase 3 | Status: TERMINATED | Results posted: 2020-03-25